GLP-1 Before Surgery or Colonoscopy: What to Ask

The answer belongs in your preprocedure call

Most patients can continue GLP-1 treatment before elective surgery or a procedure, but the anesthesia team must know you take it. The decision depends on your medication, recent dose changes, symptoms and the kind of anesthesia planned. Do not stop or continue it solely because an old internet checklist says everyone follows the same rule¹.

For a mother arranging childcare and time away from work, a canceled appointment is more than a lost morning. The practical move is to ask about the medication when the procedure is booked, before buying bowel-preparation supplies or rearranging the week. A medication plan is part of preparation, alongside the ride home and the person staying with you afterward.

Why an injection matters to anesthesia

The concern is food remaining in the stomach during general anesthesia or deep sedation. Delayed stomach emptying can allow stomach contents to enter the lungs. The Zepbound prescribing information reports pulmonary aspiration in patients taking GLP-1 medicines during procedures, and says evidence is insufficient to determine whether changing fasting or temporarily stopping treatment reduces that risk².

That is a warning about a clinical situation, not proof that every patient taking tirzepatide has a full stomach. It also explains why a routine fasting instruction does not settle the medication question. Your appointment letter may be standardized; your care needs to account for what is happening in your body now.

What changed from the blanket stop rule

The 2024 multisociety guidance moved toward individual assessment, balancing aspiration risk with the consequences of interrupting treatment. A patient taking a GLP-1 for diabetes may have a different risk from a patient taking it only for weight management. Stopping a medicine can affect glucose management and may create another problem the team must plan around³.

If two offices give conflicting instructions, ask them to reconcile the plan directly. Tell the prescriber what the procedure office requested and tell the anesthesia office who manages your prescription. A screenshot of an online recommendation cannot resolve a disagreement between the people responsible for your care. Get a clear written answer attached to your appointment.

Details that can change your plan

Recent dose escalation, significant gastrointestinal symptoms and other conditions that slow stomach emptying can change the assessment. ASA patient guidance describes measures such as a 24-hour liquid-only period, stomach ultrasound or a changed anesthesia plan; some elective procedures may need to wait until risk factors settle¹. These are options for the team, rather than instructions to arrange yourself.

Bring a concise medication record: product name, formulation, prescribed dose, last dose date and the date you last increased it. Add whether you have nausea, vomiting, constipation or abdominal pain. Include other prescriptions and supplements. You do not need to decide which detail is medically important before reporting it; that is what the assessment is for.

Colonoscopy prep is a separate set of instructions

A bowel-preparation drink clears the bowel for examination. The aspiration question concerns the stomach and airway during sedation. It is tempting to assume that finishing prep answers both questions, but they are different parts of the procedure. Confirm the medication plan with the endoscopy team instead of inferring it from the prep schedule.

Write the approved schedule in one place, including when solid food stops, which liquids are permitted, when the preparation is taken and when drinking stops. If the appointment time changes, ask whether the schedule changes too. Avoid merging one office's handout with another office's instructions: the result can be a timetable no clinician actually approved.

The same principle applies to a procedure described casually as minor. Ask what sedation or anesthesia is planned. A short appointment can still require a careful plan; the length of the procedure is not the information the anesthesia team uses by itself.

What the reports can and cannot tell you

Aspiration events reported in the Zepbound prescribing information describe patients undergoing procedures in postmarketing experience². Those reports support taking the warning seriously, but they do not provide a personal probability for your appointment. They also do not establish a universal number of days that eliminates risk. A warning and an individualized decision can both be appropriate.

This article does not claim that everyone needs extra testing or that continuing treatment is risk-free. It explains why the useful question is whether your team has assessed your circumstances. The answer should name the person making the decision and what to do if symptoms change before the appointment.

Leave with a plan for afterward, too

If the team interrupts treatment, ask the prescribing clinician when and how to resume it. Do not assume that the previous dose remains the right restart dose after a prolonged gap. Ask what to do if recovery includes vomiting, difficulty drinking or a longer period without your usual meals. Those answers should come from the team managing your treatment.

For emergencies, tell clinicians what you take and when you last took it; do not postpone urgent care to solve a medication calendar. For planned procedures, the aim is simpler: no surprises at check-in, one coordinated set of instructions, and a recovery plan that includes both the procedure and the prescription.